Bone health in pediatric transfusion‐dependent beta‐thalassemia: Circulating osteoprotegerin and RANKL system-Reference-Cited by-同舟云学术

Bone health in pediatric transfusion‐dependent beta‐thalassemia: Circulating osteoprotegerin and RANKL system

Published:2021-10-26 Issue:1 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Youssry Ilham¹^ORCID,Saad Nahla²,Madboly Mohamed²,Samy Rania M.³^ORCID,Hamed Soha T.⁴,Tawfik Hanaa⁵,Elbatrawy Salwa R.⁵,Kaddah Normeen¹,Abd Elaziz Dalia¹^ORCID

Affiliation:

1. Pediatric Department Cairo University Cairo Egypt

2. Egyptian Ministry of Health and Population Cairo Egypt

3. Chemical and Clinical Pathology Department Cairo University Cairo Egypt

4. Radiology Department Cairo University Cairo Egypt

5. Biological Anthropology Department National Research Center Cairo Egypt

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29377

Reference59 articles.

1. Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects;Skordis N;Pediatr Endocrinol Rev,2011

2. Bone disease and skeletal complications in patients with β thalassemia major

3. Osteoporosis Syndrome in Thalassaemia Major: An Overview

4. Treatment options for thalassemia patients with osteoporosis

5. Circulating osteoprotegerin and receptor activator of NF-κB ligand system in patients with β-thalassemia major

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine Complications of the Hematologic Disorders and of Their Treatment;Reference Module in Biomedical Sciences;2024

2. New Entity—Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement;Diagnostics;2022-08-09